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ABSTRACT
Previous studies have demonstrated that thyroid hormone (T3)
stimulates insulin-responsive glucose transporter (GLUT4) tran-
scription and protein expression in rat skeletal muscle. The aim of the
present study was to define a putative thyroid hormone response
element (TRE) within the rat GLUT4 promoter and thus perhaps
determine whether T3 acts directly to augment skeletal muscle
GLUT4 transcription. To this end, electrophoretic mobility shift anal-
yses were performed to analyze thyroid hormone receptor (TR) bind-
ing to a previously characterized 281-bp T3-responsive region of the
rat GLUT4 promoter. Indeed, within this region, a TR-binding site of
the standard DR14 TRE variety was located between bases 2457/
2426 andwas shown to posses a specific affinity for in vitro translated
TRs. Interestingly, however, the GLUT4 TR-binding site demon-
strated a significantly lower affinity compared to a consensus DR14
TRE, and only bound TRs appreciatively in the form of high affinity
heterodimers, in this case with the cis-retinoic acid receptor.
In conclusion, these data demonstrated the presence of a specific
TR-binding site within a T3-responsive region of the rat GLUT4 pro-
moter and thus support the supposition that thyroid hormone acts
directly to stimulate GLUT4 transcription in rat skeletal muscle.
Moreover, characterization of a novel TR-binding site with low affin-
ity suggests an additional mechanism by which the intrinsic activity
and responsiveness of thyroid hormone regulated genes may be mod-
ulated. (Endocrinology 138: 1215–1223, 1997)
THEENTRY of glucose into mammalian cells is mediatedby a family of tissue-specific plasma membrane trans-
port proteins (GLUT1 through 4), the process of which rep-
resents the rate-limiting step in glucose metabolism (1, 2). In
tissues that express the insulin-responsive glucose trans-
porter isoform (GLUT4), i.e. skeletal muscle, adipose, and
heart, the uptake of glucose is also largely dependent upon
insulin (3). In normal individuals, insulin-mediated glucose
disposal functions largely to normalize circulating plasma
glucose levels after a meal, approximately 85% of which
occurs within skeletal muscle (4). However, defects in this
process result in persistent hyperglycemia and hyperinsu-
linemia, and represent the ultimate cause of insulin resis-
tance in noninsulin-dependent diabetes mellitus (NIDDM)
(3).
The molecular defect in glucose disposal leading to
NIDDM has been suggested to reside within the insulin
signaling pathway (5–7), although cause and effect have not
been established in this disease. Nevertheless, elucidating
positive regulators of GLUT4 as well as their mechanism(s)
of action are of considerable interest as a possible treatment
in NIDDM. Overexpression of GLUT4 in transgenic diabetic
mice has been shown to be highly effective in ameliorating
postprandial hyperglycemia, primarily by stimulating basal
(noninsulin-mediated) glucose disposal (8). Previous studies
from our laboratory (9) and that of Weinstein et al. (10) have
demonstrated that thyroid hormone (T3) stimulates basal
and, to some extent, insulin-mediated glucose uptake in rat
skeletal muscle. The mechanism for this stimulatory effect of
T3 was determined to be due predominantly to an induction
of GLUT4 protein expression (9, 10). In the preceding manu-
script, GLUT4 induction by T3 was further defined to be
primarily via transcriptional induction in red muscle, and a
separate translational and/or posttranslational mechanism
in white muscle fiber types (11). Moreover, in a previous
study, constructs containing various regions of the GLUT4
upstream of a reporter gene, when transfected into C2C12
myotubes and treated with T3, isolated a 281-bp region re-
sponsive to thyroid hormone (12). However, further exper-
iments are required to determine whether T3 acts directly on
GLUT4 transcription and whether transcriptional induction
of skeletal muscle GLUT4 by T3 or a previously suggested
(11) muscle-selective T3-receptor agonist represents a viable
therapeutic strategy in NIDDM.
The effects of T3 on gene transcription are mediated di-
rectly via a family of nuclear receptor/transcription factors:
c-erbAa1, -b1, and -b2 (13–19). These thyroid hormone re-
ceptors (TRs) bind to specific thyroid hormone response
elements (TREs) consisting of hexameric half-sites [consen-
sus: AGGT(C/A)A], orientated in singlet or multiplex con-
figurations within the promoter regions of target genes. A
limited number of TREs have been elucidated; many consist
of directly repeated half-sites separated by 4 bp (DR14) (13),
whereas, an everted half-site TRE separated by 6 bp (F2) has
been reported to function as a silencer in the chick lysozyme
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promoter (20, 21). TRs bindwith high affinity to their cognate
DNA elements in both the presence and absence of T3; how-
ever, TRs only function to stimulate (on positive TREs) or
repress (on negative TREs) gene transcription in response to
binding thyroid hormone (13–15, 17–19). In contrast, unoc-
cupied TRs on positive TREs (e.g. DR14 elements) actively
repress basal transcription (22–27).
TRs bind to composite TREs as monomers; however, co-
operative interactions favor the formation of homodimers.
Moreover, TRs interact with coregulatory proteins or thyroid
hormone auxiliary proteins in vivo, some of which have been
characterized [e.g. the cis-retinoic acid receptors (RXRs)] (28–
34). TR/RXR heterodimers demonstrate higher binding af-
finities than TR homodimers, are favored in the presence of
T3, and produce larger increases in T3-induced gene expres-
sion (13, 14, 32, 33). Indeed, heterodimers are considered to
be the primary complexes mediating T3-regulated gene ex-
pression in vivo.
The aim of the present study was to determine and char-
acterize a putative TRE within the rat GLUT4 promoter and
thus perhaps establish whether T3 acts directly to stimulate
GLUT4 transcription. Sequential electrophoretic mobility
shift assay (EMSA) analyses using a previously described
281-bp T3-responsive region of the GLUT4 promoter (12)
identified a TR-binding site, orientated in the classical DR14
motif, between bases 2450 and 2434. However, in contrast
to other established TREs, the GLUT4 TR-binding element
demonstrated a significantly lower affinity, and as a likely
consequence only bound TRs appreciatively in the presence
of RXR. Therefore, these data are also suggestive of an ad-
ditional level of complexity that may govern the inducibility
and responsiveness of T3-regulated genes.
Materials and Methods
Plasmids and reticulocyte lysate-synthesized receptors
The previously described human complementary DNA clones for
c-erbAb1 and c-erbAa1 in pCMV (35) and for RXRa and retinoic acid
receptor a (RARa) complementary DNAs in pSKXR3–1 (36) were
used to program TNT T7-coupled reticulocyte lysates (Promega,
Madison, WI). Unlabeled and [35S]methionine-labeled receptors were
synthesized in parallel using in vitro translation reactions, and the
protein concentrations were determined from trichloroacetic acid-
precipitable counts according to the manufacturer’s instructions. The
synthesis of the human a1 (ha1) TR, however, is not as efficient as
those for b1 and RXRa and thus could not be used in sufficient
amounts to give optimal results in EMSAs. In some experiments
purified chick a1 TR was used to visualize a1 complexes more
readily. This receptor was the gift of Dr. H. Samuels (New York
University Medical Center, New York, NY). The isolation procedure
for chick a1 has been described previously (37) and was used here in
approximately equimolar ratios with hRXRa.
A plasmid containing a 281-bp EcoNI-BstXI fragment of the GLUT4
promoter (bases2517 to2238), which accounts for full thyroid hormone
responsiveness of 2212 bp from the transcriptional start site of GLUT4,
was obtained from Dr. J. Pessin (University of Iowa, Iowa City, IA).
Various double strandedDNAoligomers spanning this regionwere also
designed to further localize the putative GLUT4 TRE. These were syn-
thesized at the East Carolina University School of Medicine DNA-Core
Facility.
Antibodies
The N-terminal polyclonal antibody specific for rat b1 (rb1PAb,
amino acids 62–92 in rat b1) and the C-terminal a1/b cross-specific
polyclonal antibody (ra1/bPAb, amino acids 447–461 and 393–407 in rat
b1 and a1, respectively) were provided by Drs. J. Oppenheimer and H.
Schwartz (University of Minnesota, Minneapolis, MN). The hRXRa
polyclonal antibody (RXRaPAb) was the generous gift of Dr. R. Evans
(The Salk Institute, San Diego, CA).
Isolation and extraction of nuclei from rat skeletal muscle
Nuclei were isolated from rat skeletal muscle in the presence of
protease inhibitors (0.5 mm phenylmethylsulfonylfluoride, 10 mg/ml
leupeptin, 1 mg/ml aprotinin, and 10 mm EDTA) by the previously
described method of Neufer et al. (38). Approximately 500 mg purified
rat muscle nuclei were extracted using 100 ml cold (4 C) M4 extraction
buffer [20 mmHEPES (pH 7.8), 0.4 m KCl, 2 mm dithiothreitol, and 20%
glycerol] for 30min (plus protease inhibitors), and the nuclear debris and
DNA were pelleted at 12,000 rpm in a microfuge for 15 min. Nuclear
extracts were assayed for protein concentration by the method of Brad-
FIG. 1. Sequence of the previously described 281-bp thyroid hormone-responsive region of the GLUT4 promoter.Arrows show the putative TRE
half-sites (consensus AGGT(C/A)A). MyoD, Consensus sequence for myogenic differentiation factor (MyoD); MEF-2, consensus sequence for
MEF-2; AlwN1, cleavage site for restriction enzyme AlwN1. Dotted lines indicate the sequences included in double stranded DNA oligomers
synthesized to determine the position of a putative GLUT4 TRE.
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ford (39) and were used either immediately for analysis or stored at280
C until required.
EMSAs
EMSAs were performed as previously described (40). Briefly, ap-
proximately 100 ng (60,000 cpm) of a 32P-labeled double stranded DNA
oligomer were incubated with either 1 ml (10 fmol) reticulocyte lysate
synthesized receptor (1 ml hb1 and/or hRXRa) or 5 mg nuclear extract
for 30 min at room temperature in a total volume of 20 ml reaction buffer
[25 mm Tris (pH 7.8), 0.5 mm EDTA, 88 mm KCl, 1 mm dithiothreitol,
150mg/ml poly(dIzdC)-poly(dIzdC), 0.05% Triton X-100, and 12.5mg/ml
sonicated salmon sperm DNA]. For supershift experiments, 1 ml poly-
clonal antiserawas incubatedwith in vitro translated receptors for 30min
at room temperature before addition of the DNA oligomer. Reaction
mixtures were subjected to electrophoresis on a 5% nondenaturing poly-
acrylamide gel at 4 C and 40 mA (200 V) for approximately 2.5 h, and
the dried gels were exposed with intensifying screens to x-ray film for
16–48 h at 280 C.
Results
Identification of TR-binding site within a T3-responsive
region of the GLUT4 promoter
To identify a putative TREwithin the ratGLUT4promoter,
a series of electrophoretic mobility shift analyses were per-
formed using a 281-bp fragment of the rat GLUT4 promoter
(Fig. 1), previously delineated in transient transfection stud-
ies to be T3 responsive (12). EMSA using this fragment was
sufficient to first establish the presence of a TR-binding site
within the GLUT4 promoter. The binding of reticulocyte
lysate-synthesized a1 and b1 TR/RXRa heterodimers to this
281-bp fragment is shown in the four left lanes of Fig. 2
(complex composition confirmed in Fig. 6). In addition, com-
plexes were formed using rat skeletal muscle nuclear ex-
tracts, in particular one that migrates closely with the human
in vitro translated a1/RXRa heterodimer (Fig. 2, left lanes 4
and 2, respectively) and one highly abundant species with
very lowmobility. The lesser degree of ha1 TR binding to the
GLUT4 sequence as well as other TREs used throughout this
report is due to the lower efficiency of the in vitro translation
reaction for ha1, such that equimolar ratios with hb1 and
RXRa could not be used in this assay.
Using two AlwN1 restriction fragments of the 281-bp pro-
moter sequence, the GLUT4 TR-binding element was further
localized to the 59-fragment (Fig. 2). In addition, consistent
with the presence of a MyoD and/or myocyte enhancer
factor-2 (MEF-2) consensus binding site within the 59-restric-
tion fragment (Fig. 1), both the full-length and 59-AlwNI
sequences bound lowmobility complex producedwithmus-
cle nuclear extracts (left and right four lanes of Fig. 2, respec-
tively). Based on these data, three oligomers were synthe-
sized to span the 59-AlwN1 restriction fragment: oligo 1
(bases 2526/2485), oligo 2 (bases 2491/2452), and oligo 3
(bases 2460/2418) (Fig. 1), to further define the position of
the GLUT4 TRE as well as establish the putative binding of
MyoD and/or MEF activities within this thyroid hormone-
responsive region of the GLUT4 promoter. Specifically, oligo
1 encompassed the three upstream putative TRE sequences,
oligo 2 covered the MyoD and MEF consensus binding sites,
and oligo 3 spanned the remaining near-consensus TRE se-
quencewithin this AlwN1 restriction fragment (Fig. 1). Oligo
3 was not synthesized to cover the residual downstream
sequences in the 59-AlwN1 fragment, because this region is
simply composed of a stretch of AC microsatellite dinucle-
FIG. 2. EMSA using in vitro translated TR and skeletal muscle nu-
clear extractswith the full-length (2517/2237) andAlwN1 restriction
fragments (2517/2363 and 2363/2237) of the thyroid hormone-re-
sponsive GLUT4 promoter region. Lane 1, Reticulocyte lysate control;
lane 2, ha1 TR and RXRa; lane 3, hb1TR and RXRa; lane 4, 15 mg
skeletal muscle nuclear extract.
FIG. 3. EMSA using in vitro translated TRs and skeletal muscle
nuclear extracts with the chicken lysozyme F2 TRE and sequences
2526/2485 (oligo 1) of the thyroid hormone-responsive GLUT4 pro-
moter region. Lane 1, ha1; lane 2, ha1 TR andRXRa; lane 3, hb1; lane
4, hb1TR andRXRa; lane 5, 5mg skeletalmuscle nuclear extract; lane
6, 10 mg skeletal muscle nuclear extract. M, Monomer; HD, ho-
modimer or heterodimer.
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otide repeats and thus is highly unlikely to contain a specific
TR-binding element.
The bindings of in vitro translated TRs and skeletal muscle
nuclear extracts to oligo 1 and a previously characterized
TRE (the chicken lysozyme F2 TRE) (20, 21) were compared
in Fig. 3. These data clearly demonstrated that bases 2526/
2485 of the GLUT4 promoter do not contain a TR-binding
element, although the putative TRE half-sites within this
region (highlighted in Fig. 1) are close to the consensus AG-
GT(C/A)A. The experiment shown in Fig. 4, left panel, di-
rectly compared the binding of TRs and skeletal muscle
nuclear extracts to oligos 2 and 3. Consistent with the re-
spective putative consensus elements within these oligos
(Fig. 1), binding of in vitro translated TRs was localized to
oligo 3 (bases 2460/2418), whereas the postulated MEF-2
and/or MyoD binding complex was defined within oligo 2.
Moreover, competition of the oligo 2 binding species with a
large excess of an unlabeled MEF-2, but not a MyoD con-
sensus binding site, confirmed this DNA-binding species to
be composed solely of MEF-2 (Fig. 4, right panel).
In summary, these data clearly demonstrated the presence
of a TR-binding sitewithin theGLUT4promoter, the position
of which was determined to be within bases 2460/2418.
However, two overlapping near-consensus DR14 TRE se-
quences could equally be envisaged to be present within this
region (Fig. 1, solid and dashed arrows, and Fig. 5, top panel).
Therefore, to further define the boundaries and orientation
of the GLUT4 TRE, two additional oligomers were synthe-
sized with mutations designed to abrogate TR binding de-
pendent uponwhich sequence represented the true TR-bind-
ing site (Fig. 5). Mutations within the 59- to 39-orientated
putative TRE were shown to abolish TR binding, whereas
mutations within the oppositely orientated sequence did not
(Fig. 5). Therefore, these data unambiguously established the
location of the GLUT4 TR-binding site between bases 2457/
2426, composed in a classical DR14 arrangement orientated
in the 59 to 39 direction.
Characterization of the GLUT4 TR-binding site
A series of experiments was performed to characterize in
detail the specificity, affinity, and identity of TR complexes
able to form on this newly distinguished TR-binding site.
Supershift experiments (Fig. 6, lanes 1–6) first demonstrated
that the TR complexes formed using in vitro translated TRs
and hRXRa on the GLUT4 TREwere composed of TR/RXRa
heterodimers. Moreover, the successful competition of these
species with a large excess of an unlabeled oligo containing
the F2 TRE, but notwith amutated (non-TR-binding) version
of this element (M2; Fig. 6, lanes 7–12), demonstrated the
specificity of the GLUT 4 sequence for TRs.
All EMSA experiments described thus far were performed
for the most part by coincubating in vitro translated TRs with
hRXRa, principally with the intent of visualizing the maxi-
mum possible number of TR/TRE interactions. However,
only a single species has consistently been observed in these
assays, i.e. DNA binding was unable to be demonstrated by
TRs in the absence of hRXR. These data, therefore, suggest
that binding of TRs to the GLUT4 TRE may be dependent
upon heterodimerization. Hence, the GLUT4 TRE was next
FIG. 4. EMSAusingTRs,MEF-2A, and
skeletal muscle nuclear extracts with
oligomers spanning sequences 2491/
2452 (oligo 2) and 2460/2418 (oligo 3)
of the thyroid hormone-responsive
GLUT4 promoter region. Lanes 1 and 5,
Reticulocyte lysate control; lanes 2 and
6, purified chick a1 TR andRXRa; lanes
3 and 7, hb1TR and RXRa; lanes 4 and
8, 15 mg skeletal muscle nuclear ex-
tract; lane 9, 0.1 mg nuclear extract
(NE); lane 10, 0.1 mg NE and a 200-fold
excess of a MEF-2 consensus DNA-
binding element; lane 11, 0.1mgNEand
a 1000-fold excess of MEF-2 DNA; lane
12, 0.1 mg NE and a 200-fold excess of a
MyoD consensus DNA-binding ele-
ment; lane 13, 0.1 mg NE and a 1000-
fold excess of MyoD DNA.
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compared to a canonical DR14 TRE sequence composed of
perfect consensus half-sites to determine the relative ability
of these sequences to bind TRs (Fig. 7; both elements labeled
to identical specific activities). Complexes on both elements
demonstrated the characteristic downshift of heterodimeric
TR/TRE complexes and dissociation of TR homodimers in
the presence of T3 (Fig. 7). However, TR binding to the
GLUT4 TRE was overall considerably lower, and as a likely
consequence, homodimer and even monomeric binding ev-
ident for b1 TRs on the canonical DR14 element, was not
detectable on the GLUT4 TR-binding site.
This phenomenonwas next studied inmore detail, initially
by comparing a titration curve for the binding of increasing
amounts of in vitro translated b1 TR with a constant con-
centration of RXRa to the GLUT4 and canonical DR14 TR-
binding sites. The results of this experiment (Fig. 8) demon-
strated that unlike the canonical DR14, only at the highest
b1TR concentrationwas TRhomodimermarginally apparent
on the GLUT4 TRE.
With regard to a potential mechanism for this observation,
as the binding affinity/specificity of TRs is presumably de-
termined by the DNA sequence of the binding site, a final
experiment was performed using a series of oligos synthe-
sized with single base substitutions to determine a crucial
base or sequence dictating the lower affinity and perhaps
putative heterodimer-selective binding of the GLUT4 TR-
binding element (Fig. 9). Specifically, these mutations were
designed to replace nonconsensus half-site bases with con-
sensus nucleotides. In addition, various substitutions were
introduced within the intervening and flanking regions of
the GLUT 4 TR-binding element, e.g. mutant oligo 7 was
synthesized, replacing all the intervening and flanking bases
with those present in the canonical DR14 TRE.
The results of the binding of in vitro translated b1 and
b11RXRa receptors to thesemutant GLUT4 TREs are shown
in Fig. 9. Interestingly, bases within the intervening and/or
flanking sequences were also shown to be crucial for TR
binding; in particular intervening bases 2 and 3. In contrast,
the mutations in oligo 5 and oligo 6 (which converts the first
base of the 39-TRE half-site to the consensus) apparently
imparted an additional affinity to these sequences, the degree
of which and perhaps complex formation on would seem to
be comparablewith those of the canonical DR14 TRE. There-
fore, in combination with the previous titration experiment,
these data suggest that it is the overall lower affinity of the
GLUT4 sequence that accounts for the visualization of only
the more avid heterodimer in these experiments, i.e. a quan-
titative, rather than qualitative, phenomenon. This conclu-
sion would also be supported by the reduced binding and
formation of only heterodimer observed by mutant 7,
wherein all the flanking and intervening bases were substi-
tuted with those from the canonical TR-binding element.
In conclusion, these data demonstrated that the newly
identified GLUT4 TRE has a specific affinity for TRs. How-
ever, in contrast to other established TREs, GLUT4 TRE was
shown to have a much lower affinity, and this property
appears to be responsible for the observation that only high
affinity TR/heterodimeric receptors bind appreciatively on
this TRE. Moreover, combined with the results of a previous
study that demonstrated this region of the GLUT4 promoter
to confer thyroid hormone responsiveness in transfection
studies (12), these data indicate that the effects of T3 onGLUT
4 transcription are likely to be mediated directly by this
TR-binding element. However, formal proof of this hypoth-
esis requires additional functional analyses using mutations
within this TR-binding element.
Discussion
The primary aim of this study was to analyze the binding
of TRs and nuclear extracts to a previously identified thyroid
hormone-responsive region of the GLUT4 promoter (12) and
thus perhaps determine whether thyroid hormone acts di-
rectly to stimulate GLUT4 transcription in rat skeletal muscle
(11). Indeed, consistent with this hypothesis, a series of
EMSA analyses clearly demonstrated the presence of a spe-
FIG. 5. EMSA using two mutated oligomers spanning the sequence
2457/2426 determined the orientation of the GLUT4 TRE. Sequence
and EMSA of oligos DR14 and DR24. lanes 1 and 4, Reticulocyte
lysate control; lanes 2 and 5, purified chick a1 TR and RXRa; lanes
3 and 6, hb1 TR and RXRa. *, Mutation sites [all replaced with an
adenine (A), except the one original A, which was replaced with a
thymine].
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FIG. 7. EMSA comparing the relative
affinity and TR complexes formed on
theGLUT4TREwith a canonicalDR14
TRE sequence. GLUT4 and DR14
TREs were labeled to an identical spe-
cific activity, and equal counts were
used for EMSA analysis. Lane 1 and 9,
Purified a1 TR; lanes 2 and 10, purified
a1 TR and T3 (1 3 10
27 M); lanes 3 and
11, hb1; lanes 4 and 12, hb1 and T3;
lanes 5 and 13, purified a1 and RXRa;
lanes 6 and 14, purified a1, RXRa, and
T3; lanes 7 and 15, hb1 andRXRa; lanes
8 and 17, hb1, RXRa, and T3.
FIG. 6. EMSA to determine the iden-
tity and binding specificity of TR com-
plexes formed on the GLUT4 TRE.
Lanes 1–6, EMSA supershift experi-
ment usingTR isoform-specific antibod-
ies to determine the composition of TR/
GLUT4 TRE complexes. Lane 1,
Purified chick a1 and hRXRa; lane 2,
purified chick a1, hRXRa, and a1 poly-
clonal antibody; purified chick a1,
hRXRa, and RXRa polyclonal antibody;
lane 4, hb1, hRXRa, and b1 polyclonal
antibody; hb1, hRXRa, and RXRa poly-
clonal antibody. Lanes 7–12, EMSA
with competing DNA to determine the
binding specificity of the GLUT4 TRE
for TRs: lane 7, purified chick a1 and
hRXRa; lane 8, purified chick a1,
hRXRa, and a 200-fold excess of cold F2
TRE; lane 9, purified chick a1, hRXRa,
and a 200-fold excess of a cold mutant
(non-TR binding) TRE (M2); lanes 10–
12, same as for lanes 7–9, except using
in vitro translated b1 TR and RXRa.
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cific DR14 TR-binding site between bases2457/2426 of the
GLUT4 promoter fragment. However, given the similar de-
viations from the consensus [AGGT(C/A)A] of this con-
firmed TR-binding site and the other three putative TRE
half-sites located further upstream, it is not immediately
clear why the latter sequences did not also display TR-bind-
ing activity. Conceivably, the second and third half-sites of
the latter tandem sequence can be discounted due to their
nonoptimal separation distance (3 bp). However, the first
and second elements form an apparently viable DR14 ele-
ment. Nevertheless, this can probably be explained by the
fact that neither of these half-sites contains a consensus thy-
mine [AGGT(C/A)A] at the fourth position.
The exquisite specificity of base sequences directing pro-
tein-DNA interaction(s) was similarly demonstrated in the
mutation experiment, which revealed that intervening and
flanking sequences surrounding the GLUT4 half-sites were
also crucial for mediating TR binding. Indeed, we may have
been fortunate in that the mutations introduced within the
intervening and flanking regions to discern the orientation of
the GLUT4 TRE did not also abrogate TR binding. However,
none of the mutations analyzed in Fig. 9 directly altered the
propensity of the GLUT4 TRE to bind heterodimers. More-
over, certain substitutions (in particular the conversion of the
first base in the 39 half-site to the consensus adenine; mutant
oligo 6) that enhanced the affinity of the GLUT4 TRE, re-
sulted in binding properties similar to those of the canonical
DR14 TRE. Of note, increased binding to the mutation oligo
6 would be consistent with the fact that TRs in heterodimeric
complexes are considered to bind this particular half-site. In
contrast, mutant oligo 7, in which all bases other than those
within the GLUT4 TRE half-sites were replaced with the
corresponding sequences in the canonical DR14, demon-
strated properties comparable to those of the wild-type
GLUT4 TRE. These data, therefore, suggest that the apparent
heterodimer specificity observed for the GLUT4 TR-binding
site is simply a function of the overall lower affinity of the
half-sites within this element. Indeed, the titration experi-
ment demonstrated the GLUT4 sequence to be equally de-
FIG. 8. EMSA titration curve to determine the specificity of the
GLUT4 TRE (oligo sequence 2452/2431; TCCGGGTTACT-
TCGGGGCATTG) for TR/RXR heterodimers compared to the canon-
ical DR14 TRE. Lanes 1 and 5, 2 ml RXRa; lanes 2 and 6, 2 ml RXRa
and 1 ml b1TR; lanes 3 and 7, 2 ml RXRa and 2 ml hb1; lanes 4 and
8, 2 ml RXRa and 4 ml hb1TR.
FIG. 9. EMSA using a series of GLUT4 TRE mutants to determine a
putative base(s) imparting specificity for TR/RXR heterodimers. The
sequences of GLUT4 TRE mutants (italic, mutated base) and EMSA
using the GLUT4 TRE and GLUT4 TRE mutants 1–7 (lanes 1–8,
respectively) are shown. Lane 9, Canonical DR14 TRE.
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ficient in binding both homodimers and heterodimers com-
pared to a canonical DR14 TR-binding element (estimated to
be approximately 5-fold from densitometric scanning).
Finally, characterization of a low affinity TR-binding site
has a number of implications for thyroid hormone-regulated
genes, the first of which would presumably be the induc-
ibility of responsive genes. Indeed, the degree of transcrip-
tional induction observed for the GLUT4 gene (;2.5 under
chronic hyperthyroid vs. hypothyroid conditions) (11) com-
pared to genes containing high affinity TRE(s) (e.g. malic
enzyme; transcription stimulated 3- to 4-fold in the liver of
euthyroid rats) (43) is consistent with this hypothesis. Sec-
ondly, as 1) TRs bind DNA in the presence and absence of
thyroid hormone, 2) unoccupied TRs actively repress basal
transcription, and 3) heterodimers demonstrate higher af-
finities over homodimers and are favored in the presence of
T3 (13), a low affinity TRE would have special relevance for
thyroid hormone-regulated genes. For example, one can
speculate that although a low affinity TRE would not illicit
as large a T3 induction compared to a high affinity TRE, by
the same token, in the absence of T3 a low affinity TREwould
not be subjected to such a great degree of basal repression.
A previous study suggested a criterion by which different
combinations of weak and strong artificial TRE half-sites
modulate TR complex formation and T3 responsiveness of
thyroid hormone-regulated genes (44). In this classification,
the GLUT4 TRE presumably falls into the category of either
a weak/weak (w/w) or, more likely from the high affinity
imparted to the mutant 6, a strong/weak half-site compo-
sition. Interestingly, consistentwith our observations, both of
these previously described TREs were weakly T3 responsive
(44). Moreover, distinct from all other TRE combinations,
these elements were also dependent upon RXR tomediate T3
induction in transfection assays.Unfortunately, however, the
basal repression properties of a w/w or strong/weak TRE
were not investigated in this study (44).
Interestingly, both the half-site sequences, the immedi-
ately flanking bases, and three of the four intervening se-
quences of the GLUT4 TRE are absolutely conserved among
humans, mice, and rats (Fig. 10). Their conservation would,
therefore, further suggest the probable functionality of this
low affinity TRE aswell as the importance of sequences other
than those within the TR half-sites for mediating TR binding.
Indeed, one can envisage that during the evolution of genes,
the properties of promoter regulatory elements, e.g. affinity,
may be similarly selected so that they compliment the func-
tion of the particular gene product, i.e. for a TRE; a low
affinity TRE(s) may predominate in genes that need to be
constitutively expressed, but under certain conditions need
to be up-regulated to some extent, e.g. GLUT4 (11). In con-
trast, a higher affinity TREs would be highly responsive to
thyroid hormone, but would also be subjected to a greater
degree of active repression by unoccupied heterodimers
and/or homodimers. Such a TREwould, therefore, be highly
sensitive to changes in T3 status/availability and may be
advantageous for imparting high inducibility on, for in-
stance, temporally expressed genes (Fig. 11).
In conclusion, these studies demonstrated the presence of
a specific TR-binding element within a region of the GLUT4
promoter previously found to impart T3 responsiveness (12).
These data, therefore, corroborate the supposition that the
effects of T3 on GLUT4 transcription are direct. However,
formal demonstration of this hypothesis must await proof of
nonfunctionality in transient transfection assays of mutants
within the GLUT4 TR-binding site. Nevertheless, the GLUT4
TR-binding element was also shown to possess a signifi-
cantly lower affinity than a conventional DR14 TR-binding
element and only bound TRs significantly in combination
with RXR. These data, therefore, suggest anothermechanism
bywhich the intrinsic basal activity and T3 responsiveness of
thyroid hormone-regulated genes may be modulated.
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